...
lab-img

Standard Biotools Inc, Common Stock

LAB

NSQ

$1.985

-$0.22

(-9.95%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$796.63M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.24M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.21 L
$3.04 H
$1.985

About Standard Biotools Inc, Common Stock

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameLABSectorS&P500
1-Week Return2.32%-2.06%-0.55%
1-Month Return32.33%-1.92%2.72%
3-Month Return-2.22%-10.4%7.66%
6-Month Return-3.17%-4.6%10.15%
1-Year Return1.79%4.06%27.53%
3-Year Return-47.49%1.94%32.31%
5-Year Return-38.16%36.48%89.2%
10-Year Return-93.6%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue117.24M138.14M130.58M97.95M106.34M[{"date":"2019-12-31","value":84.87,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.53,"profit":true},{"date":"2022-12-31","value":70.9,"profit":true},{"date":"2023-12-31","value":76.98,"profit":true}]
Cost of Revenue52.96M54.82M53.31M60.90M55.89M[{"date":"2019-12-31","value":86.97,"profit":true},{"date":"2020-12-31","value":90.02,"profit":true},{"date":"2021-12-31","value":87.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.78,"profit":true}]
Gross Profit64.28M83.33M77.27M37.05M50.45M[{"date":"2019-12-31","value":77.14,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":92.73,"profit":true},{"date":"2022-12-31","value":44.47,"profit":true},{"date":"2023-12-31","value":60.55,"profit":true}]
Gross Margin54.83%60.32%59.17%37.83%47.44%[{"date":"2019-12-31","value":90.89,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.1,"profit":true},{"date":"2022-12-31","value":62.71,"profit":true},{"date":"2023-12-31","value":78.65,"profit":true}]
Operating Expenses116.12M134.36M144.72M153.26M113.49M[{"date":"2019-12-31","value":75.77,"profit":true},{"date":"2020-12-31","value":87.67,"profit":true},{"date":"2021-12-31","value":94.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":74.05,"profit":true}]
Operating Income(51.84M)(51.04M)(67.46M)(116.20M)(76.60M)[{"date":"2019-12-31","value":-5183900000,"profit":false},{"date":"2020-12-31","value":-5103600000,"profit":false},{"date":"2021-12-31","value":-6745900000,"profit":false},{"date":"2022-12-31","value":-11620500000,"profit":false},{"date":"2023-12-31","value":-7660000000,"profit":false}]
Total Non-Operating Income/Expense(19.14M)(6.64M)(24.00K)(81.05M)(2.26M)[{"date":"2019-12-31","value":-1914500000,"profit":false},{"date":"2020-12-31","value":-663700000,"profit":false},{"date":"2021-12-31","value":-2400000,"profit":false},{"date":"2022-12-31","value":-8105400000,"profit":false},{"date":"2023-12-31","value":-226300000,"profit":false}]
Pre-Tax Income(66.70M)(54.10M)(63.66M)(192.93M)(74.20M)[{"date":"2019-12-31","value":-6670500000,"profit":false},{"date":"2020-12-31","value":-5410100000,"profit":false},{"date":"2021-12-31","value":-6366000000,"profit":false},{"date":"2022-12-31","value":-19292800000,"profit":false},{"date":"2023-12-31","value":-7420400000,"profit":false}]
Income Taxes(1.92M)(1.08M)(4.42M)(2.83M)452.00K[{"date":"2019-12-31","value":-423.67,"profit":false},{"date":"2020-12-31","value":-239.16,"profit":false},{"date":"2021-12-31","value":-978.54,"profit":false},{"date":"2022-12-31","value":-626.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(64.79M)(53.02M)(59.24M)(190.10M)(74.66M)[{"date":"2019-12-31","value":-6479000000,"profit":false},{"date":"2020-12-31","value":-5302000000,"profit":false},{"date":"2021-12-31","value":-5923700000,"profit":false},{"date":"2022-12-31","value":-19009800000,"profit":false},{"date":"2023-12-31","value":-7465600000,"profit":false}]
Income From Continuous Operations(64.79M)(53.02M)(59.24M)(190.10M)(75.72M)[{"date":"2019-12-31","value":-6479000000,"profit":false},{"date":"2020-12-31","value":-5302000000,"profit":false},{"date":"2021-12-31","value":-5923700000,"profit":false},{"date":"2022-12-31","value":-19009800000,"profit":false},{"date":"2023-12-31","value":-7572500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(64.79M)(53.02M)(59.24M)(190.10M)(74.66M)[{"date":"2019-12-31","value":-6479000000,"profit":false},{"date":"2020-12-31","value":-5302000000,"profit":false},{"date":"2021-12-31","value":-5923700000,"profit":false},{"date":"2022-12-31","value":-19009800000,"profit":false},{"date":"2023-12-31","value":-7465600000,"profit":false}]
EPS (Diluted)(0.85)(0.73)(0.78)(2.44)(0.85)[{"date":"2019-12-31","value":-85,"profit":false},{"date":"2020-12-31","value":-73,"profit":false},{"date":"2021-12-31","value":-78,"profit":false},{"date":"2022-12-31","value":-244,"profit":false},{"date":"2023-12-31","value":-85,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

LAB
Cash Ratio 3.04
Current Ratio 3.76
Quick Ratio 3.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LAB
ROA (LTM) -14.69%
ROE (LTM) -37.25%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LAB
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LAB
Trailing PE NM
Forward PE NM
P/S (TTM) 5.28
P/B 1.68
Price/FCF NM
EV/R 3.50
EV/Ebitda NM

FAQs

What is Standard Biotools Inc share price today?

Standard Biotools Inc (LAB) share price today is $1.985

Can Indians buy Standard Biotools Inc shares?

Yes, Indians can buy shares of Standard Biotools Inc (LAB) on Vested. To buy Standard Biotools Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LAB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Standard Biotools Inc be purchased?

Yes, you can purchase fractional shares of Standard Biotools Inc (LAB) via the Vested app. You can start investing in Standard Biotools Inc (LAB) with a minimum investment of $1.

How to invest in Standard Biotools Inc shares from India?

You can invest in shares of Standard Biotools Inc (LAB) via Vested in three simple steps:

  • Click on Sign Up or Invest in LAB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Standard Biotools Inc shares
What is Standard Biotools Inc 52-week high and low stock price?

The 52-week high price of Standard Biotools Inc (LAB) is $3.04. The 52-week low price of Standard Biotools Inc (LAB) is $1.21.

What is Standard Biotools Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Standard Biotools Inc (LAB) is

What is Standard Biotools Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Standard Biotools Inc (LAB) is 1.68

What is Standard Biotools Inc dividend yield?

The dividend yield of Standard Biotools Inc (LAB) is 0.00%

What is the Market Cap of Standard Biotools Inc?

The market capitalization of Standard Biotools Inc (LAB) is $796.63M

What is Standard Biotools Inc’s stock symbol?

The stock symbol (or ticker) of Standard Biotools Inc is LAB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top